Effect of synbiotic supplementation in patients with polycystic ovary syndrome

Not Applicable

Recruiting

• Conditions: polycystic ovary syndrome.; Polycystic ovarian syndrome

• Registration Number: IRCT20100408003664N19
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 68

Inclusion Criteria

• Women with PCOS aged 20-40 years
• Diagnosis of PCOS in patients by Gynecologist and according to Rotterdam Standard 2003•
The BMI range is between 40-25 m ^ 2/ kg

Exclusion Criteria

• History of thyroid disorders, hyperprolactinemia, Cushing's syndrome, liver and kidney disease, cardiovascular disease, digestive diseases (food allergies, celiac disease, irritable bowel disease), high blood pressure and diabetes. Diagnosis of non-disease By asking the patient, using the existing tests and under the supervision of the doctor will be done.
• Pregnancy and breastfeeding
• Consumers of anti-obesity drugs and blood lipid lowering drugs, anticoagulants and glucocorticoids
• Using a weight loss diet
• smoking
• Athlete or regular exercise
• Sensitivity to synbiotic and probiotic capsules
• Antibiotic use a month ago
• Use of any dietary supplements in the last 2 months or during the study
• Receiving probiotics, perebiotic, synbiotics during the last three months and during the study
• Regular consumption of probiotic products

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting blood sugar. Timepoint: Begining and end of the intervention. Method of measurement: Analysing With Spectrophotometer.;Level of Serum Insulin. Timepoint: Begining and end of the intervention. Method of measurement: Analysing with ELISA.;HOMA-IR. Timepoint: Begining and end of the intervention. Method of measurement: Calculated According to The Formula.;Total Cholestrol. Timepoint: Begining and end of the intervention. Method of measurement: Analysing With Spectrophotometer.;HDL-C. Timepoint: Begining and end of the intervention. Method of measurement: Analysing With Spectrophotometer.;LDL-C. Timepoint: Begining and end of the intervention. Method of measurement: Calculated According to The Friedewald Formula.;TG. Timepoint: Begining and end of the intervention. Method of measurement: Analysing With Spectrophotometer.

Secondary Outcome Measures

Name	Time	Method
Apelin. Timepoint: Beginning and end of intervention. Method of measurement: Analysing With ELISA.;Anthropometric indexes. Timepoint: Beginning and end of intervention. Method of measurement: Measuring with scales and meters.